TipRanks
Advertisement
Advertisement

MNKD Stock Latest News

MannKind management to meet with Cantor
The FlyMannKind management to meet with Cantor
8d ago
MNKD
MannKind and Rose Pharma sign licensing and collaboration agreement
PremiumThe Fly
MannKind and Rose Pharma sign licensing and collaboration agreement
10d ago
MNKD
MannKind Prepares Shelf Registration for Potential Stock Offering
PremiumCompany Announcements
MannKind Prepares Shelf Registration for Potential Stock Offering
29d ago
8K
MNKD
MannKind price target lowered to $13 from $14 at Wells Fargo
PremiumThe Fly
MannKind price target lowered to $13 from $14 at Wells Fargo
1M ago
MNKD
MannKind reports Q2 EPS (6c), consensus 2c
PremiumThe Fly
MannKind reports Q2 EPS (6c), consensus 2c
1M ago
MNKD
MNKD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMNKD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MNKD
MannKind price target raised to $14 from $11 at Wells Fargo
Premium
The Fly
MannKind price target raised to $14 from $11 at Wells Fargo
2M ago
MNKD
MannKind reports ‘positive’ Phase 1b INFLO-1 results
Premium
The Fly
MannKind reports ‘positive’ Phase 1b INFLO-1 results
2M ago
MNKD
MannKind Raises $50 Million in Private Placement
PremiumCompany Announcements
MannKind Raises $50 Million in Private Placement
2M ago
8K
MNKD
MannKind announces FDA approval of Furoscix ReadyFlow
PremiumThe Fly
MannKind announces FDA approval of Furoscix ReadyFlow
2M ago
MNKD
MannKind announces $50M private placement
PremiumThe Fly
MannKind announces $50M private placement
2M ago
MNKD
MannKind nearing ‘underappreciated catalyst,’ says H.C. Wainwright
PremiumThe Fly
MannKind nearing ‘underappreciated catalyst,’ says H.C. Wainwright
2M ago
MNKD
MannKind’s MNKD-201 Trial: A New Inhaled Bet on Idiopathic Pulmonary Fibrosis
PremiumCompany AnnouncementsMannKind’s MNKD-201 Trial: A New Inhaled Bet on Idiopathic Pulmonary Fibrosis
2M ago
MNKD
MannKind’s Inhaled IPF Drug Reaches Key Milestone, Setting Up the Next Move for MNKD
Premium
Company Announcements
MannKind’s Inhaled IPF Drug Reaches Key Milestone, Setting Up the Next Move for MNKD
2M ago
MNKD
MannKind announces milestones in development of nintedanib DPI for IPF
Premium
The Fly
MannKind announces milestones in development of nintedanib DPI for IPF
4M ago
MNKD
MannKind Gains FDA Approval for Afrezza Pediatric Use
PremiumCompany Announcements
MannKind Gains FDA Approval for Afrezza Pediatric Use
4M ago
8K
MNKD
MannKind price target raised to $11 from $10 at Wells Fargo
PremiumThe Fly
MannKind price target raised to $11 from $10 at Wells Fargo
4M ago
MNKD
MannKind announces FDA approval of Afrezza for use in children aged 6 and older
PremiumThe Fly
MannKind announces FDA approval of Afrezza for use in children aged 6 and older
4M ago
MNKD
MannKind Released From Major Afrezza Trial Obligation
PremiumCompany Announcements
MannKind Released From Major Afrezza Trial Obligation
4M ago
8K
MNKD
MannKind Shareholders Reaffirm Board, Pay, and Auditor Roles
PremiumCompany AnnouncementsMannKind Shareholders Reaffirm Board, Pay, and Auditor Roles
4M ago
8K
MNKD
MannKind Leans Into Growth Amid Earnings Volatility
Premium
Company Announcements
MannKind Leans Into Growth Amid Earnings Volatility
4M ago
MNKD
MannKind price target lowered to $7 from $8 at Mizuho
Premium
The Fly
MannKind price target lowered to $7 from $8 at Mizuho
4M ago
MNKD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >